Fig 1.
Flow of included patients through the trial.
Table 1.
Baseline characteristics of participants stratified by SHR quartile levels.
Table 2.
Baseline characteristics of the Survivors and Non-survivors groups.
Fig 2.
Kaplan–Meier survival analysis curves for all-cause 28-day ICU mortality.
(A) Overall population; (B) patients with diabetes; (C) patients without diabetes; Q1:SHR ≤ 0.72; Q2:Quartiles 2:0.72 < SHR ≤ 0.99;Q3:Quartiles 3:0.99 < SHR ≤ 1.36;Q4:Quartiles 4:SHR > 1.36.
Table 3.
Univariate and Multivariate Cox regression analysis for 28-day ICU mortality.
Table 4.
Cox proportional hazard ratios (HR) for 28-day ICU mortality.
Fig 3.
Multivariable-adjusted restricted cubic spline analyses of SHR for 28-day ICU mortality.
Fig 4.
Receiver operating characteristic curves of SHR, FBG, and HbA1c in predicting 28-day ICU mortality.
(A) Overall population; (B) patients without diabetes; (C) patients without diabetes; SHR, stress hyperglycemia ratio; FBG, fasting blood-glucose; HbA1c, hemoglobin A1c.
Fig 5.
Forest plots for subgroup analyses of SHR with 28-day ICU mortality.